在2型糖尿病患者的门诊患者中,射程时间和黄昏现象之间的关系
Xiangyu Gao1, Hongmei Li1, Yuan Yu1
1Department of Endocrinology, East Hospital, Tongji University School of Medicine, Shanghai, 200120, People's Republic of China.
概括
黄昏现象,即晚餐前高血糖,经常影响2型糖尿病的管理. 较低的射程时间 (TIR) 与这种情况有关,这表明TIR可以预测其发生.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 糖尿病管理 糖尿病管理
背景情况:
- 黄昏现象是晚餐前过渡性高血糖,影响2型糖尿病 (T2DM) 的葡萄糖波动和血糖控制.
- 持续的葡萄糖监测 (CGM) 有助于诊断黄昏现象.
- 了解黄昏现象的流行和预测因素对于优化T2DM管理至关重要.
研究的目的:
- 调查T2DM患者临床黄昏现象 (CLDP) 的频率.
- 检查T2DM患者中CLDP和时间范围 (TIR) 之间的关系.
- 确定TIR作为暮色现象的潜在预测因素.
主要方法:
- 102名T2DM患者接受了为期14天的CGM.
- 根据晚餐前和午餐后的葡萄糖差异来诊断CLDP.
- 分析了CGM衍生的指标和临床特征,包括TIR,超范围时间 (TAR) 和葡萄糖变化.
主要成果:
- 在T2DM队列中,CLDP患病率为11.76%.
- 与非CLDP组相比,患有CLDP的患者表现出较低的TIR和更高的TAR.
- 后勤回归显示了CLDP和TIR之间的显著负相关性,即使经过对混因素进行调整.
结论:
- 临床黄昏现象在T2DM患者中很常见.
- 时间在范围 (TIR) 与CLDP的存在有显著的相关性.
- TIR可以作为T2DM中黄昏现象的独立负面预测因素.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
93
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
93
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Insulin: Dosing Regimen and Adverse Effects
215
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
215
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319


